# OnCo record prospect (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/prospect/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "prospect", "NCT01515787" ;
  schema:name "PROSPECT (Alliance N1048)"@en ;
  schema:description "PROSPECT showed that most people with intermediate-risk rectal cancer can skip pelvic radiotherapy altogether: chemotherapy alone before surgery, with radiotherapy held back for the few whose tumours did not shrink, cured just as many."@en ;
  schema:url <https://onco.cc/trials/prospect/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01515787>, <https://doi.org/10.1056/NEJMoa2303269> ;
  onco:status "positive" ;
  onco:phase "2/3" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/rectal-cancer/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/fluorouracil/>, <https://onco.cc/drugs/capecitabine/> ;
  onco:institutions <https://onco.cc/institutions/alliance-oncology/> ;
  onco:terms <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/terms/total-mesorectal-excision/> .
